IP Library Assignment 054963/0131
Patent Assignment
Reel/Frame 054963/0131

Change of Name

Recorded: 2021-01-14 Pages: 4
Assignor
LION BIOTECHNOLOGIES, INC.
Executed: 2017-06-27
Assignee
IOVANCE BIOTHERAPEUTICS, INC.
999 SKYWAY ROAD, SUITE 150, SAN CARLOS, CALIFORNIA, 94070
Covered Properties (8)
Processes for Production of Tumor Infiltrating Lymphocytes and Uses of Same in Immunotherapy
Application: 17/127,768 →
Publication: US 2021/0128620
Processes for Production of Tumor Infiltrating Lymphocytes and Uses of Same in Immunotherapy
Application: 17/127,840 →
Publication: US 2021/0128621
Processes for Production of Tumor Infiltrating Lymphocytes and Uses of Same in Immunotherapy
Application: 17/127,790 →
Publication: US 2021/0106625
Processes for Production of Tumor Infiltrating Lymphocytes and Uses of Same in Immunotherapy
Application: 17/127,795 →
Publication: US 2021/0137984
Processes for Production of Tumor Infiltrating Lymphocytes and Uses of Same in Immunotherapy
Application: 17/147,073 →
Publication: US 2021/0128622
Processes for Production of Tumor Infiltrating Lymphocytes and Uses of Same in Immunotherapy
Application: 17/147,080 →
Publication: US 2021/0128623
Processes for Production of Tumor Infiltrating Lymphocytes and Uses of Same in Immunotherapy
Application: 17/147,090 →
Publication: US 2021/0128624
Processes for Production of Tumor Infiltrating Lymphocytes and Uses of Same in Immunotherapy
Application: 17/147,096 →
Publication: US 2021/0128625
Related Assignments (1)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Jan 14, 2021
From: BENDER, JAMES; WARDELL, SETH; LOTZE, MICHAEL T.
To: LION BIOTECHNOLOGIES, INC.
Reel/Frame 054922/0149 →